Bernhard Tribukait

4PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 29, 2023
Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer.

Bernhard Tribukait, Per-Olof Lundgren, Anders Kjellman

|Mar 16, 2022
Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer.

Per-Olof Lundgren, Bernhard Tribukait, Anders Kjellman

|Nov 13, 2021
Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer.

Bernhard Tribukait

|May 20, 2020
Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume.

Bernhard Tribukait

Pageof 1

Frequent Collaborators

2 joint publications

Per-Olof Lundgren

1 joint publications

Kiran Jagarlmundi